Structural racism and inequity in cancer clinical trial participation: time for solutions.
作者信息
Pal Abhijit, Moussa Rayan Saleh, Smith Ben, Brady Bernadette, Karikios Deme, Boyle Frances, Chua Wei
机构信息
Department of Medical Oncology, Liverpool Hospital, Sydney, NSW, Australia.
University of Sydney, NSW, Australia.
出版信息
JNCI Cancer Spectr. 2024 Sep 2;8(5). doi: 10.1093/jncics/pkae089.
Abstract
摘要
相似文献
1
Structural racism and inequity in cancer clinical trial participation: time for solutions.癌症临床试验参与中的结构性种族主义和不平等：是时候寻求解决方案了。
JNCI Cancer Spectr. 2024 Sep 2;8(5). doi: 10.1093/jncics/pkae089.
2
Re: Structural racism and inequity in cancer clinical trial participation: time for solutions.关于：癌症临床试验参与中的结构性种族主义与不平等：是时候寻求解决方案了。
JNCI Cancer Spectr. 2025 Mar 3;9(2). doi: 10.1093/jncics/pkaf013.
3
The role of structural racism and geographical inequity in diabetes outcomes.结构性种族主义和地理不平等在糖尿病结局中的作用。
Lancet. 2023 Jul 15;402(10397):235-249. doi: 10.1016/S0140-6736(23)00909-1. Epub 2023 Jun 22.
4
Structural Racism and Cancer: Calls to Action for Cancer Researchers to Address Racial/Ethnic Cancer Inequity in the United States.结构性种族主义与癌症：美国癌症研究人员解决种族/民族癌症不平等问题的行动呼吁。
Cancer Epidemiol Biomarkers Prev. 2022 Jun 1;31(6):1243-1246. doi: 10.1158/1055-9965.EPI-21-1179.
5
Structural Racism and Severe Maternal Morbidity in New York State.纽约州的结构性种族主义与严重孕产妇发病情况
Clin Med Insights Womens Health. 2019 Jun 14;12:1179562X19854778. doi: 10.1177/1179562X19854778. eCollection 2019.
6
Separate and unequal: Structural racism and infant mortality in the US.隔离且不平等：美国的结构性种族主义与婴儿死亡率
Health Place. 2017 May;45:140-144. doi: 10.1016/j.healthplace.2017.03.012. Epub 2017 Mar 28.
7
Racial inequity in preterm delivery among college-educated women: The role of racism.大学学历女性中早产的种族不平等：种族主义的作用。
Paediatr Perinat Epidemiol. 2021 Jul;35(4):482-490. doi: 10.1111/ppe.12772. Epub 2021 May 6.
8
Structural racism and reflections from Latinx heavy drinkers: Impact on mental health and alcohol use.结构性种族主义与拉丁裔重度饮酒者的反思：对心理健康和酒精使用的影响。
J Subst Abuse Treat. 2021 Aug;127:108352. doi: 10.1016/j.jsat.2021.108352. Epub 2021 Mar 16.
9
Building the Transdisciplinary Resistance Collective for Research and Policy: Implications for Dismantling Structural Racism as a Determinant of Health Inequity.构建跨学科抵抗集体以进行研究和政策制定：消除结构性种族主义作为健康不平等决定因素的影响。
Ethn Dis. 2020 Jul 9;30(3):381-388. doi: 10.18865/ed.30.3.381. eCollection 2020 Summer.
10
Structural Racism: The Rules and Relations of Inequity.结构性种族主义：不公正的规则和关系。
Ethn Dis. 2021 May 20;31(Suppl 1):293-300. doi: 10.18865/ed.31.S1.293. eCollection 2021.
引用本文的文献
1
What is the role of common sense oncology in the Western Pacific?常识性肿瘤学在西太平洋地区的作用是什么？
Lancet Reg Health West Pac. 2025 Aug 12;61:101660. doi: 10.1016/j.lanwpc.2025.101660. eCollection 2025 Aug.
2
Re: Structural racism and inequity in cancer clinical trial participation: time for solutions.关于：癌症临床试验参与中的结构性种族主义与不平等：是时候寻求解决方案了。
JNCI Cancer Spectr. 2025 Mar 3;9(2). doi: 10.1093/jncics/pkaf013.
本文引用的文献
1
Mediators of racial and ethnic inequities in clinical trial participation among patients with cancer, 2011-2023.癌症患者参与临床试验中种族和民族不平等的中介因素，2011-2023 年。
JNCI Cancer Spectr. 2024 Sep 2;8(5). doi: 10.1093/jncics/pkae085.
2
Are community oncology practices with or without clinical research programs different? A comparison of patient and practice characteristics.社区肿瘤学实践是否有临床研究项目有何不同？患者和实践特征的比较。
JNCI Cancer Spectr. 2024 Jul 1;8(4). doi: 10.1093/jncics/pkae060.
3
Broadening Eligibility Criteria and Diversity among Patients for Cancer Clinical Trials.拓宽癌症临床试验患者的资格标准和多样性。
NEJM Evid. 2024 Apr;3(4):EVIDoa2300236. doi: 10.1056/EVIDoa2300236. Epub 2024 Mar 26.
4
Racialized economic segregation and inequities in treatment initiation and survival among patients with metastatic breast cancer.转移性乳腺癌患者在治疗起始和生存方面存在种族经济隔离和治疗不公平现象。
Breast Cancer Res Treat. 2024 Jul;206(2):411-423. doi: 10.1007/s10549-024-07319-5. Epub 2024 May 3.
5
Socioeconomic status and inequities in treatment initiation and survival among patients with cancer, 2011-2022.2011-2022 年癌症患者的社会经济地位与治疗启动和生存的不平等。
JNCI Cancer Spectr. 2023 Aug 31;7(5). doi: 10.1093/jncics/pkad058.
6
Improving Access to Cancer Clinical Trials for Patients From Culturally and Linguistically Diverse Backgrounds in Australia: A Survey of Clinical and Research Professionals.改善澳大利亚文化和语言背景多样化患者参与癌症临床试验的机会：对临床和研究专业人员的调查。
JCO Oncol Pract. 2023 Nov;19(11):1039-1047. doi: 10.1200/OP.23.00291. Epub 2023 Sep 7.
7
Racial and Ethnic Inequities in US Oncology Clinical Trial Participation From 2017 to 2022.2017 年至 2022 年美国肿瘤学临床试验参与中的种族和民族不平等。
JAMA Netw Open. 2023 Jul 3;6(7):e2322515. doi: 10.1001/jamanetworkopen.2023.22515.
8
The accuracy of race & ethnicity data in US based healthcare databases: A systematic review.美国医疗保健数据库中种族和民族数据的准确性：系统评价。
Am J Surg. 2023 Oct;226(4):463-470. doi: 10.1016/j.amjsurg.2023.05.011. Epub 2023 May 18.
9
The Lack of Race and Ethnicity Data in Australia-A Threat to Achieving Health Equity.澳大利亚缺乏种族和民族数据——实现健康公平的威胁。
Int J Environ Res Public Health. 2023 Apr 17;20(8):5530. doi: 10.3390/ijerph20085530.
10
Practical strategies for creating diversity, equity, inclusion, and access in cancer clinical research: DRIVE.在癌症临床研究中实现多样性、公平性、包容性和可及性的实用策略：DRIVE。
Blood Adv. 2023 Apr 25;7(8):1507-1512. doi: 10.1182/bloodadvances.2022008220.
Zotero 插件